LONDON (Alliance News) - Drug discovery and development company C4X Discovery Holdings PLC on Wednesday said Clive Dix will move from executive chairman to chief executive with immediate effect.
Dix joined the group as non-executive chairman in October 2014.
Sam Williams, a non-executive director, will be interim chairman while a permanent replacement is sought.
Dix is the former chief executive of Convergence Pharmaceuticals, a spin-out from GlaxoSmithKline PLC, which was sold to US biotechnology company Biogen for USD675.0 million in January 2015.
C4X shares were up 1.6% to 96.50 pence Wednesday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.